Tesamorelin.
Tesamorelin is a synthetic analog of growth hormone-releasing factor (GRF) with a trans-3-hexenoyl group attached to the tyrosine at position 1. With the molecular formula C₂₂₁H₃₆₆N₇₂O₆₇S and a molecu...
Lab Verified
Clinical Grade
PMID Cited
Mechanism of Action.
Published preclinical research has characterized the following molecular pathways and receptor interactions for Tesamorelin.
GHRH Receptor
Tesamorelin binds to GHRH receptors with enhanced affinity due to hexenoyl modification, activating Gs-protein signaling.
Clinical Literature
Research review on Tesamorelin molecular characterization.
Preclinical studies have characterized the molecular properties and receptor binding profiles of Tesamorelin in standardized assay systems.
Tesamorelin structure-activity relationship analysis.
Structure-activity relationship studies have examined the functional domains and binding characteristics of Tesamorelin in cell-free and cell-based systems.
RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.
Related Compounds.
GH SecretagoguesCJC no DAC
$43.00C152H252N44O42 · 3367.9 g/mol
For in vitro research use only. Not for human consumption.
GH SecretagoguesCJC/IPA
$62.00Blend · Mixed
For in vitro research use only. Not for human consumption.
GH SecretagoguesFOXO4
$196.00C228H388N86O64 · 5358.06 g/mol
For in vitro research use only. Not for human consumption.